BRAF and thyroid gland carcinoma: Mutations in protein BRAF can affect the expression of noncellular components of tumor ECM (extracellular matrix) via MAPK signaling pathway to upregulate thyroid cancer microenvironmental regulator TSP1, thus changing the microenvironment in PTC [4].